APOE and Alzheimer disease: This has been shown in clinical epilepsy populations (Mackenzie and Miller, 1994; Tai et al., 2016) and APOE4 targeted replacement mice, a genetic knock-in model of AD (Klein et al., 2014; Nuriel et al., 2017), where network hyperexcitability leads to increased accumulation of AD pathology.